ACINETWORK is a multidisciplinary network (7 academic groups and 1 industrial partner as Beneficiaries along with 8 Associated Partners) that aims to forge 10 young professionals within an integrated research training programme in academia and industrial environments on the design and development of novel glycoconjugate vaccine candidates as treatment against severe and life-threatening infections caused by the multidrug-resistant bacterium Acinetobacter baumannii, a major cause of nosocomial diseases.